SinglePoint positioned for success in the cannabis market through its rapidly expanding portfolio of holdings positions Company reduces risk of changing state and federal laws by not touching the plant, but instead focusing on tools and services for the cannabis industry Proprietary bitcoin payment solution in development Specialized holding company SinglePoint, Inc. (OTC: SING) was […]

The company reported revenues of $589,000 for 2016 Mergers and acquisitions have enabled AppSwarm to enter the e-commerce, health and education segments In-house software development has produced virtual reality products and expanded the app incubation/acceleration program AppSwarm (OTC: SWRM), a publicly traded technology development and incubation acceleration firm, has experienced a momentum in 2017 that […]

Proprietary biosynthesis process to produce cannabinoids Cannabinoid bioinformatics system that identifies optimal R&D pathways Lead candidate targeting billion dollar market Despite the awe-inspiring shadow cast by the moon on August 21, 2017, there’s no eclipse in sight for InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). The Vancouver, Canada-based company continues its research and development (R&D) […]

Moxian praised for new joint venture strategy to help penetrate key markets in China Crystal Equity Research projects Moxian’s sales reaching $2.3 million in FY2018 Moxian adding three to its board of directors, including Liu Shu Juan, CEO of Shewn International Group, Inc. Moxian, Inc.’s (NASDAQ: MOXC) price target of $5.25 remains unchanged in the […]

Commencing volume manufacturing, allowing ramp-up of distribution and sales Partnering with Bitcoin Capital to create proprietary bitcoin payment solution to serve cannabis industry SinglePoint, Inc. (OTC: SING) continues making great strides in its strategic diversification efforts and has become a compelling and diversified player within the cannabis market. In a recent article, SinglePoint was mentioned […]

Alzheimer’s is a leading cause of dementia in adults in the United States IGC’s cannabis-based drug may reverse the buildup of beta-amyloid plaque Hyalolex and other phytocannabinoid-based drugs are fueling potential for the company’s market valuation growth Alzheimer’s disease is currently the sixth-leading cause of death in the nation and the most common cause of […]

Avoids federal legal issues by sourcing hemp grown outside U.S. and focusing on federally legal cannabidiol (CBD) Targets rapidly developing cannabis market, with cannabidiol alone expected to reach over $2 billion by 2020 Distribution already covers all 50 states, and is growing internationally PotNetwork Holdings, Inc. (OTC: POTN), based in Fort Lauderdale, Florida, is a […]

The precast concrete manufacturer, for the half ended the same date, recorded a 14.1% rise in revenues and a 377% spike in net income Safety barrier project in Northern Virginia has SMID working at full capacity seven days a week to meet deadlines Company has backlog of $30.2 million, optimistic about profitable performance in 2018 […]

Industry leader projects cryptocurrency bitcoin, which has achieved $4,000 price, can reach $100,000 within five years Company provides processing solution for “unbankable” risk markets, such as legalized cannabis SinglePoint releases new investor relations kit that details its acquisition strategy, profiles key executives (http://dtn.fm/eZ4HE) SinglePoint, Inc. (OTC: SING) finds itself at the intersection of two fast-growth […]

Core operations transitioned to phytocannabinoid-based therapies Four trial candidates targeting chronic pain, Alzheimer’s and other conditions Unique approach combining existing therapies with cannabinoids India Globalization Capital, Inc. (NYSE MKT: IGC) is developing disruptive new pharmaceutical therapies to fight a variety of ailments. Currently, the Maryland-based corporation has a pipeline of cannabis-based combination candidates under development […]